Neurogene(NGNE) - 2025 Q1 - Quarterly Results

Financial Results - Neurogene Inc. reported financial results for Q1 2025, with a focus on operational performance and financial condition[5] - The financial results include key metrics that will be elaborated in the attached press release[5] - The report does not include specific financial figures or performance metrics in the provided content[6] Press Release - The press release detailing these results was issued on May 9, 2025, and is attached as Exhibit 99.1[5] - The report was signed by Christine Mikail, President and Chief Financial Officer, on the date of the press release[11] Company Information - The company is listed on The Nasdaq Global Market under the trading symbol NGNE[3] - Neurogene Inc. is not classified as an emerging growth company under the Securities Act of 1933[4] - The company’s principal executive office is located in New York, NY[2] Compliance and Filing - The filing is intended to comply with the requirements of the Securities Exchange Act of 1934[9] - The report includes an Interactive Data File as part of its exhibits[7]